2021 will mark the 10th edition of BioFIT. On this occasion, key industry and academic players, long-standing participants of BioFIT will look back at the developments that have shaped the collaborative landscape of early-stage research in the biopharma industry.
What are the main changes in the collaborations between Academia & Industry? Pharma & Start-ups? How has the nature of these partnership relationships evolved? Are some kinds of collaborations favoured? By whom? New models for peer-to-peer collaboration? Newcomers? Results vs. risks? Are these collaborations really speeding us innovation process? Do they participate in reducing costs?
Tim Dafforn - University of Birmingham